Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks

By Leah Douglas WASHINGTON, March 12 (Reuters) - Compounded weight-loss drugs that contain vitamin B12 and the main ingredient in Eli Lilly's Zepbound could present health risks to consumers due to a ...
Food Safety News

New technology could allow consumers to test for spoilage at home and put bacterial detection in food packaging

Researchers have developed new methods to test food for bacterial contamination that are faster and do not require expert ...
C&EN

March 13 Policy Watch: FDA streamlines its process for approving biosimilar drugs

In another development, 25 states have petitioned to join a lawsuit and defend the EPA’s decision to rescind the climate endangerment finding ...

PDA Publishes Revised Technical Report No. 56: A Clear, Phase Appropriate Roadmap for GMP Compliant Development of Biological Drug Substances

PDA Publishes Revised Technical Report No. 56: A Clear, Phase Appropriate Roadmap for GMP Compliant Development of Biological Drug Substances Technical Report No. 56 (Revised 2026) outlines a ...
360Dx

MeMed Receives FDA Breakthrough Device Designation for Capillary Blood Version of BV Test

The company's BV Flex test measures patient immune proteins in capillary blood samples to determine whether an individual has a bacterial or viral infection.